Low-fat diets have been shown to increase plasma concentrations of lipoprotein (a) [Lp(a)], a preferential lipoprotein carrier of oxidized phospholipids (OxPL) in plasma, as well as small, dense LDL particles. We sought to determine whether increases in plasma Lp(a) induced by a low-fat, high-carbohydrate (LFHC) diet are related to changes in OxPL and LDL subclasses. We studied 63 healthy subjects after 4 weeks of consuming, in random order, a highfat, low-carbohydrate (HFLC) diet and a LFHC diet. Plasma concentrations of Lp(a) (P < 0.01), OxPL/apoB (P < 0.005) and OxPL-apo(a) (P < 0.05) were significantly higher on the LFHC diet compared to the HFLC diet, whereas LDL peak particle size was significantly smaller (P < 0.0001). Diet-induced changes in Lp(a) were strongly correlated with changes in OxPL/apoB (P < 0.0001). The increases in plasma Lp(a) levels after the LFHC diet were also correlated with decreases in medium LDL particles (P < 0.01) and increases in very small LDL particles (P < 0.05). These results demonstrate that induction of increased levels of Lp(a) by a LFHC diet is associated with increases in oxidized phospholipids and with changes in LDL subclass distribution that may reflect altered metabolism of Lp(a) particles.
INTRODUCTION
Oxidized phospholipids (OxPL) play an important role in inflammation and in progression of atherosclerosis (1, 2) . Levels of OxPL on apolipoprotein B-100 (OxPL/apoB) lipoproteins can be measured with the monoclonal antibody E06, which binds OxPL but not native phospholipids (3) . OxPL/apoB levels are elevated in patients with acute coronary syndromes (4, 5) , and in coronary (6) , carotid and peripheral arterial disease (7) and predict death and myocardial infarction in unselected populations (8). Recently, Bergmark et al. (9) showed that lipoprotein(a) [Lp(a) ] is the preferential lipoprotein carrier of OxPL in human plasma, and other studies (4, 5, (10) (11) (12) have shown strong associations between OxPL/apoB and Lp(a).
Elevated plasma Lp(a) concentrations are associated with increased risk of cardiovascular disease (CVD) (13, 14) , and there is increasingly strong data that they may be causal in the etiology of myocardial infarction (15, 16) . Lp(a) consists of an LDL-like particle covalently attached to apolipoprotein (a) [apo(a)] by a single disulfide bond (17) . Plasma Lp(a) levels vary in the population from nearly undetectable to > 100 mg/dL. This heterogeneity is mainly determined by variation at the apo(a) gene locus (18) , and is inversely related to the number of kringle IV repeats (19) . Additional single nucleotide polymorphisms (SNP), such as the recently described LPA I4399M and rs10455872 SNPs, which is associated with marked elevation of Lp(a) levels, coronary artery disease and myocardial infarction (20) (21) (22) (23) (24) , are associated with even further heterogeneity in Lp(a) levels.
Although the variability in Lp(a) concentration is largely genetically determined, environmental influences and pharmacological therapies may also affect Lp(a) levels. In particular low-fat diets have been shown to result in small but significant increases in Lp(a) (25, 26) . Furthermore, such diets can induce inverse changes in levels of large vs. small LDL as well by on August 23, 2010 www.jlr.org Downloaded from 4 as in levels of medium vs. very small LDL particles (27) . In the present study, we have tested the impact of a combined low-fat, high-carbohydrate diet on plasma Lp(a) concentrations and whether any changes are related to changes in both OxPL and LDL subclasses.
METHODS

Study design and experimental diets
All subjects underwent a diet intervention (randomized crossover design) involving 4 week of a high-fat, low-carbohydrate (HFLC) diet and 4 week of a low-fat, high-carbohydrate (LFHC) diet. The HFLC diet was designed to provide 40% of energy from fat (13.0% saturated, 11.0% monounsaturated, 13.8% polyunsaturated and 3.4% trans), 45% carbohydrate and 15% protein. The LFHC diet was designed to provide 20% of energy from fat (4.9% saturated, 9.9% monounsaturated, 5.1% polyunsaturated and 2.4% trans), 65% carbohydrate and 15% protein.
There were no differences in dietary cholesterol and the ratio of simple:complex carbohydrate was ~50:50 between the diets ( Table 1) . Nutrient composition was calculated using the Minnesota Nutrition Data System software, version 2.1, developed by the Nutrition Coordinating Center, University of Minnesota, Minneapolis.
Study participants
Subjects were recruited from an extensive database and the community at large through telephone and written materials. The study participants were healthy, non-smoking men and women at least 20 years old who had been free of chronic disease in the last 5 years, were not by on August 23, 2010 www.jlr.org Downloaded from taking medication known to affect lipid metabolism and had a resting blood pressure less than 160/105 mmHg. Other eligibility criteria included a body weight < 130% of ideal, total cholesterol and LDL cholesterol less than the 95 th percentile for age and sex, triglyceride < 500 mg/dL, blood glucose < 126 mg/dL and plasma Lp(a) levels > 3 mg/dL. Men (n = 61) and women (n=2) were combined for analysis because the results were not different after exclusion of the 2 women participants. We previously reported lipoprotein fractionation data in a subset (n=33) of the individuals (28) .
Registered dietitians instructed the participants on the experimental diets at a group orientation class and contacted the subjects weekly to maintain diet adherence and weight maintenance. Four-day food records (Thursday through Sunday) were used to assess compliance with the experimental diets. All subjects were compliant, with estimated daily deviations averaging < 5% of total calories. Nutrient analysis of the 4-day food record was performed by Nutrition Data System software. Subjects were asked to refrain from alcohol and maintain their regular level of physical activity throughout the study. All subjects gave informed consent under a protocol approved by the Institutional Review Boards at Children's Hospital Oakland and EO Lawrence Berkeley National Laboratory, University of California, Berkeley.
Laboratory measurements
Blood samples were obtained after an overnight fast after the experimental diets (week 4). Plasma samples were prepared within 2 h of collection from venous blood collected in tubes containing Na 2 EDTA (1.4 g/L) and a preservative cocktail of protease and bacterial inhibitors.
Plasma was kept at 4ºC throughout processing. Plasma total cholesterol and triglyceride Chemiluminescent ELISA was used to measure the content of OxPL per apoB-100 (apoB) lipoprotein using the murine monoclonal antibody E06, which binds to the phosphocholine (PC) headgroup of oxidized but not native phospholipids (4) . A 1:50 dilution of plasma in phosphate-buffered saline was added to microtiter wells coated with murine monoclonal antibody MB47, which specifically equally binds all apoB-100 (LDL, Lp(a), IDL, VLDL) particles (31, 32) . Under these conditions, a saturating amount of apoB-100 was added to each well and consequently an equal number of apoB particles are captured in each well for all assays. The content of OxPL per apoB was then determined with biotinylated E06 as previously described (4, 5, 10, 33) . Thus, by design, the OxPL/apoB measurement is independent of apoB or LDL cholesterol levels. The apoB in the denominator of the OxPL/apoB does not represent the plasma apoB-100 level, but the amount of apoB-100 captured on each microtiter well plate.
Because most of the OxPL are present on Lp(a) in this assay format, as previously shown (9), the OxPL/apoB measure primarily detects OxPL on Lp(a).
We also measured OxPL directly on Lp(a) [OxPL-apo(a)] particles using a variation of the chemiluminescent ELISA technique for OxPL/apoB. Unlike apoB levels which differ by ~3-by on August 23, 2010 www.jlr.org Downloaded from 5 fold among subjects, Lp(a) plasma levels can range ~1000 fold among subjects, and therefore it is not possible to saturate the microtiter well plates with Lp(a) in subjects with low Lp(a) levels (~20 mg/dl), which represents the majority of patients. Therefore, it is impossible to develop an OxPL/apo(a) assay in such patients that reflects the OxPL content per apo(a) particle like the OxPL/apoB assay. Instead, the assay was performed at a non-saturating dilution of plasma (1:2500) which is in the linear range of Lp(a) levels in this assay format. Murine monoclonal antibody LPA4, which binds apo(a) (10), was plated on microtiter well plates (5 µg/ml) and used to capture Lp(a) from plasma. OxPL was then detected with E06 as described above. We report this assay as OxPL-apo(a) as relative light units (RLU) of E06 immunoreactivity, which closely reflects the total OxPL content on Lp(a). Unlike the OxPL/apoB assay, this assay does not detect the amount of OxPL per apo(a) particle or the small amount of OxPL that may be present on non-Lp(a) apoB particles, therefore the data are complementary (9). Non-denaturing polyacrylamide gradient gel electrophoresis with lipid staining of plasma was performed as described previously for determination of peak LDL and Lp(a) particle diameters (34) (35) (36) .
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Statistical analysis
JMP statistical software (version 7.0; SAS Institute Inc.) was used for statistical analysis.
Data are presented as means ± SD. Shapiro-Wilk test was used to test the skewness of the distribution. Non-normally distributed variables (triglyceride, apoA-I, apoB, Lp(a), OxPL/apoB, LDL size and lipoprotein subclass mass concentrations) were log-transformed before analysis.
Paired t-test was used to evaluate differences in lipids, lipoproteins and apolipoproteins between the HFLC diet and the LFHC diet. Wilcoxon signed rank test was used to evaluate differences in OxPL on Lp(a) between the HFLC and the LFHC diet. Spearman's correlation coefficients were used to evaluate the relationship between diet-induced changes in lipids, lipoproteins, apolipoproteins, Lp(a) and OxPL/apoB. Multivariate model analysis was used to determine factors contributing to the diet-induced change in Lp(a). The independent variables were changes in OxPL/apoB, triglyceride, LDL cholesterol, HDL cholesterol, apoB and apoA-I. P values < 0.05 were considered statistically significant.
RESULTS
The baseline characteristics of the participants are presented in Table 2 . As shown in Table 3 , plasma concentrations of triglycerides (P < 0.0001), apoB (P < 0.05), Lp(a) (P < 0.01),
OxPL/apoB (P < 0.005) and OxPL-apo(a) (P < 0.05) were significantly higher with the LFHC diet than with the HFLC diet. In contrast, total cholesterol (P = 0.06), LDL cholesterol (P < 0.05), HDL cholesterol (P < 0.0001) and apoA-1 (P < 0.0001) were lower on the LFHC diet.
Plasma lipoprotein mass concentrations (mg/dL) and LDL and Lp(a) peak particle diameters (Å) are shown in significantly increased on the LFHC diet. Large and medium LDL decreased significantly, while small and very small LDL increased on the LFHC diet compared to the HFLC diet. As expected, the LFHC diet significantly decreased mean LDL peak particle diameter from 262 to 257 Å.
However, mean Lp(a) peak particle diameter did not differ between the diets. Table 5 shows that diet-induced changes in Lp(a) were significantly correlated with changes in OxPL/apoB (r = 0.49, P < 0.0001) and LDL cholesterol (r = 0.40, P < 0.005). In contrast, there were no significant associations between diet-induced changes in Lp(a) and plasma triglyceride, total cholesterol (P = 0.08), HDL cholesterol, apoB (P = 0.07) and apoA-I.
Increases in Lp(a) with the LFHC diet were strongly related to increases in OxPL/apoB (P < 0.0001) (Figure 1) . Multivariate model analysis showed the associations between diet-induced changes in Lp(a) and changes in OxPL/apoB were independent of changes in plasma triglyceride, total cholesterol, LDL cholesterol, HDL cholesterol, apoA-I and apoB (data not shown). Furthermore, increases in OxPL/apoB with the LFHC diet were positively associated with LDL cholesterol (P < 0.01), apoB (P < 0.05) and total cholesterol (P = 0.06) (data not shown).
We found a reciprocal relationship between the diet-induced changes in medium and very small LDL (r = -0.46, P < 0.0005) and large and small LDL (r = -0.31, P < 0.05) (data not shown). The diet-induced changes in Lp(a) were positively correlated to changes with medium LDL (P < 0.01) ( Table 5 ) (Figure 2 ) and negatively with changes in very small LDL (P < 0.05) ( Table 5 ). Note that as shown in Lp(a) peak particle diameter was positively correlated with LDL peak particle diameter during the LFHC diet (P < 0.01), but not on the HFLC diet (P = 0.12) (data not shown) and dietinduced changes in peak particle diameter of LDL and Lp(a) were not correlated (P = 0.97) ( Table 4 ).
DISCUSSION
The results of this dietary intervention study utilizing a randomized cross-over design demonstrate that a low-fat, high-carbohydrate diet increases levels of both Lp(a) and OxPL on apoB-100 lipoproteins (OxPL/apoB), and that this response involves a diet-induced increase in
OxPL on Lp(a) particles. Furthermore, the correlated changes in Lp(a) and OxPL/apoB were independent of changes in plasma triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol, apoA-1 and apoB.
The measurement of OxPL on apoB-100 particles in the circulation has generated novel insights into the atherogenicity of Lp(a) (33) . Initially, the OxPL/apoB assay using murine monoclonal antibody E06 was designed to measure "minimally modified LDL". However, it was subsequently learned from multiple clinical and experimental studies that most of the E06- have noted significant increases of ~10-50% in OxPL/apoB, and Lp(a) with various doses of pravastatin and atorvastatin in the MIRACL (4) and REVERSAL (38) trials, in children with familial hypercholesterolemia (39) and in subjects with hypercholesterolemia (40) .
Diets low in total and saturated fat have been shown to increase plasma Lp(a) levels (25, 26, 41) and there is evidence that this effect may be specific for saturated fat (41) . Increases in both Lp(a) and OxPL/apoB with no significant changes in LDL cholesterol or apoB, were previously reported in a study of 37 women who consumed diets with reduced fat and high or low vegetable content. However the baseline comparison diet in this study was not controlled and its composition, estimated from 4-day food records, indicated multiple differences in average macronutrient composition compared with the experimental diets, and a range of fat intakes (36 ± 6%) that overlapped those of the experimental diets (31%), making it difficult to assess specific dietary influences on Lp(a) and OxPL/apoB response (26) .
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Notably, we have demonstrated that increases in OxPL/apoB occurs in response to low fat, low cholesterol diets in rabbits, which do not have Lp(a) and where apoB, rather than Lp(a), is the OxPL carrier. We have made similar observations in cynomolgous monkeys, which have circulating Lp(a), but whose Lp(a) does not bind OxPL (42) . In both the rabbit and primate studies, the increase in OxPL/apoB in plasma was associated with reduced content of OxPL in the vessel wall along with concomitant evidence of reduced oxidative stress (43). Although the mechanistic underpinnings of these changes cannot be determined from these studies, in composite they suggest that increases in plasma OxPL/apoB in response to therapeutic measures, perhaps including diet, may reflect a beneficial response within the artery wall leading to reduced OxPL content. In support of improved vascular health, a recent analysis from the MIRACL trial showed that individuals with the largest increases in OxPL/apoB were those who were felt to benefit the most from statins, such as younger patients with fewest risk factors (44) .
Clinical studies are underway to evaluate whether increases in OxPL/apoB in response to statins predict improved clinical outcomes.
Plasma levels of Lp(a) are thought to be determined primarily by the rate of hepatic synthesis and secretion of apo(a), which then binds to newly secreted apoB-containing lipoproteins, generating Lp(a) (45) . Clearance of Lp(a) on the other hand is not as well understood, but studies suggest that the LDL receptor is not involved. Therefore, increased Lp(a) in response to diet is likely to result from altered hepatocyte handling of apo(a) and apoB synthesis. Low-fat diets are recommended to reduce risk of coronary heart disease, but LFHC diets have been shown to induce a more atherogenic lipoprotein profile in healthy individuals by increasing small, dense LDL particles (Table 3) , reducing HDL cholesterol and increasing plasma triglyceride levels (Table 4 ) (27) . LFHC diets result in increased concentrations of by on August 23, 2010 www.jlr.org Downloaded from 13 triglyceride-rich lipoproteins (TRLs) (46) and a reciprocal shift from medium size LDL particles to very small LDL (27) ( Table 4 ). The increase in plasma Lp(a) levels with a LFHC diet may be due to changes in TRL metabolism since apo(a) has been associated with TRLs, and this TRLapo(a) association has been suggested to be atherogenic (28, (47) (48) (49) . Furthermore, the increase in plasma Lp(a) on a LFHC is associated with increased plasma apoC-III bound to apoB-containing lipoproteins and with the enrichment of TRL-apo(a) with apoC-III (28) .
Increases in Lp(a) after the LFHC diet were positively correlated with changes in medium LDL particles suggesting that the metabolism of Lp(a) and medium LDL may be coordinately regulated. Thus, the decrease in medium LDL and the increase in Lp(a) are proportionally less after the LFHC diet. Furthermore, we have shown an inverse correlation between diet-induced changes of Lp(a) and very small LDL such that the larger increase in very small LDL with a LFHC diet is associated with a smaller increase in Lp(a) (P < 0.05). Sixteen percent of the variance in diet-induced changes in Lp(a) was explained by the reciprocal changes in medium and very small LDL particles. Moreover, the strength of this relationship may have been underestimated due to the fact that the S f 0-3 fraction including very small LDL also includes a portion of plasma Lp(a) particles (50) . After adjusting for changes in medium and very small LDL, the diet-induced increase in Lp(a) was substantially greater (mean 2.85 mg/dL vs. 2.17 mg/dL) suggesting the shift in metabolism of these two LDL subclasses may be diverting the formation or increasing the catabolism or clearance of Lp(a), hence limiting the diet-induced increase in Lp(a)-associated OxPL.
One limitation is that the study population was primarily made up of men. Another concern is that there was no washout period between the two diets; however, we (51) 
